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Osteoclast fusionCell fusion process is a critical, rate-limiting step in osteoclastogenesis but themechanisms that regulate fusopod
formation are not deﬁned. We characterized fusopod generation in cultured pre-osteoclasts derived from cells
stably transfected with a plasmid that expressed a short, actin ﬁlament binding peptide (Lifeact) fused to
mEGFP that enables localization of actin ﬁlaments in living cells. Fusion was initiated at fusopods, which are
cell extensions of width N2 μmand that are immunostained formyosin-X at the extension tips. Fusopods formed
at the leading edge of larger migrating cells and from the tail of adjacent smaller cells, both of which migrated in
the same direction. Staining for DC-STAMP was circumferential and did not localize to cell–cell fusion sites.
Compared with wild-type cells, monocytes null for Rac1 exhibited 6-fold fewer fusopods and formed 4-fold
fewer multinucleated osteoclasts. From time-lapse images we found that fusion was temporally related to the
formation of coherent and spatially isolated bands of actin ﬁlaments that originated in cell bodies and extended
into the fusopods. These bands of actin ﬁlaments were involved in cell fusion after approaching cells formed
initial contacts. We conclude that the formation of fusopods is regulated by Rac1 to initiate intercellular contact
during osteoclastogenesis. This step is followed by the tightly regulated assembly of bands of actin ﬁlaments in
fusopods, which lead to closure of the intercellular gap and ﬁnally, cell fusion. These novel, actin-dependent
processes are important for fusion processes in osteoclastogenesis.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Multinucleated osteoclasts (OCs) are specialized, short-lived cells
that are essential for bone remodeling and the maintenance of normal
bone architecture and function. OCs are terminally differentiated cells
that form by the fusion of pre-osteoclasts (preOCs) [1]. PreOCs are
tartrate-resistant acid phosphatase (TRAcP)-positive mononuclear
cells derived from monocyte/macrophage-lineage precursor cells
that form in bony microenvironments or in specialized cell culture
conditions.
Osteoclast differentiation is thought to occur as a result of three
sequential and inter-connected steps. First, cells become fusion-
competent, which is initiated by a combination of the growth factor,
macrophage colony stimulating factor (M-CSF; produced bymonocytes,
granulocytes, endothelial cells and ﬁbroblasts) and by the receptor acti-
vator of nuclear factor kappa B ligand (RANKL [2]; produced by stromalBMM, bonemarrowmonocyte;
n; M-CSF, macrophage colony
nuclear factor kappa B ligand;
ndritic cell-speciﬁc transmem-
ing, University of Toronto, 150
16 978 6841; fax.: +1 416 978
g).cells, osteoblasts and T-cells). PreOCs are thought to secrete chemokines
and related molecules that attract neighboring preOCs and facilitate ag-
gregation prior to the actual fusion process [3]. Although preOCs express
OC-speciﬁc markers (e.g. TRAcP) and exhibit bone-resorbing activity,
bone-resorption by TRAcP-positive mononuclear cells is much slower
than resorption mediated by mature OCs [4,5]. Indeed, the formation
of OCs is indispensable for bone resorption since the efﬁciency of this
process is directly proportional to the size of OCs and the number of
nuclei [6–8]. The next step of OC differentiation includes the migration,
aggregation and intercellular attachment of fusion-competent cells as a
result of the apposition of their plasmamembranes. The ﬁnal step of OC
differentiation is the fusion of plasma membranes of adjacent preOCs
and the comingling of their cytoplasmic contents to create a new
functional and uniﬁed cellular entity [9]. Immature OCs display dendrit-
ic extensions that are comprised of numerous ﬁlopodia. As these cells
progressively undergo fusion events with other immature multinuclear
OCs or mononuclear preOCs, they form large, mature OCs with smooth-
edged plasma membranes [10].
While the differentiation of myeloid precursor cells into OCs has
been examined in depth, the mechanisms that mediate the fusion of
preOCs are not as well-deﬁned. Cell fusion is thought to be a pro-
grammed process [11] that ensures temporally-appropriate OC forma-
tion. Although the migration and aggregation of preOCs are essential
for the formation of multinucleated OCs, the close apposition or actual
contact of adjacent preOCs does not necessarily lead to cell fusion.
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not based on the proximity of cell membranes alone [10]. In spite of
this observation, the study of preOC fusion has largely focused on the
identiﬁcation of putative membrane fusion receptors. The macrophage
fusion receptor (also known as SIRPα), CD47 [12], CD44 [13] and
E-cadherin [14] have all been implicated as fusion receptors. Recent
work has focused on the dendritic cell-speciﬁc trans-membrane protein
(DC-STAMP) [15–17], which is essential for the fusion of preOCs [18].
DC-STAMP-deﬁcient mice do not form multinucleated OCs and exhibit
an osteopetrotic phenotype, which is not caused by defective cell differ-
entiation, but appears to arise solely because of a preOC fusion defect.
The critical molecules involved in the recruitment of preOCs, their
transition into fusion-competent cells, the intercellular recognition
systems, and their attachment and fusion have been reviewed [19].
However, attempts to deﬁne the regulatory mechanisms involved in
preOC fusion that lead to OC formation have been complicated by the
nature of cell fusion. The actual fusion process is brief so the molecular
events that regulate fusion are visible only transiently at the outset of
the fusion process [12]. Notably, cytoskeletal polymers contribute
extensively to cell shape and organization [20] and the regulation of
cytoskeletal proteins in the function of mature OC has been studied
extensively [21]. In particular, the actin cytoskeleton plays an important
role in preOC migration and polarization [22].
Actin ﬁlaments are especially important for the formation of
podosomes in preOCs, which are primary adhesive structures that con-
tribute to the sealing zones of actively resorbing cells [23–25]. In preOCs,
actin-associated force generation is coordinatedwithpodosomeassembly
and disassembly, which facilitate cell migration [26]. Actin ﬁlament
assembly is also involved in the formation of cell extensions such as
ﬁlopodia and lamellipodia, mechanosensory organelles at the leading
edge that initiate and guide cell migration. The formation of actin
ﬁlament-enriched cell extensions and the direct interdigitation of the
plasma membranes of adjacent fusing cells have been observed in the
formation of giant cells induced by IL-4 [27,28].While limited information
is available on how the actin cytoskeleton is regulated during osteoclasto-
genesis, especially in OC fusion [10], it is known that macrophage and
syncytia fusion is disrupted by cytochalasins and latrunculin, thereby im-
plicating actin assembly in cell fusion [29,30]. Despite recent reports that
associated ﬁlopodia with the fusion of preOCs [10,31], the involvement of
actin assembly in the formation of OC has not been completely deﬁned.
Accordingly, to examine the role of actin ﬁlaments in preOC fusion, we
established a stable Lifeact–mEGFP-transfected RAW264.7 cell line in
which recombinant soluble RANKL (sRANKL) is used to drive cell fusion.
With this cell line and direct, real-timemicroscopic imaging of OC fusion,
we found that ﬁlopodial-enriched cell extensions, designated here as
fusopods,mediate preOC fusion,which leads to the formation ofmultinu-
cleated OCs.
2. Materials and methods
2.1. Establishment of stable RAW264.7 cells expressing Lifeact–mEGFP
As described previously [32], pmEGFP–N1–Lifeact from Roland
Wedlich-Soldner was ampliﬁed with a primer pair 5′-GCGCAGAT
CTATGGGTGTCGCAGATTTGATCAAGAAA-3′ and 5′-GCGCGAATTCCTAT
TACTTGTACAGCTCGTCCATGCCGAG-3′. The peptide sequence
MGVADLIKKFESISKEE, was translated from 5′-ATGGGTGTCGCAGATT
TGATCAAGAAATTCGAAAGCATCTCAAAGGAAGAA-3′. The resulting PCR
product was digested with BglII and EcoRI and ligated into the
corresponding sites of a retrovirus vector pMSCVpuro (Clontech). The
construct (pMSCVpuro–Lifeact–mEGFP) and the packaging plasmid
pVSV-G (Clontech) were co-transfected into GP-293 cells (Clontech)
with FuGENE® HD Transfection Reagent (Promega, Madison, WI). The
resulting viruses were transduced into RAW264.7 cells (passage
3) (ATCC, Manassas, VA; Cat. no. TIB-71; generously provided by Keying
Li and Morris Manolson at the Faculty of Dentistry, University ofToronto). The newly-received cells from ATCC are designated here as
passage 1 [33]. Cells were maintained in complete Dulbecco's Modiﬁed
Eagle's Medium (DMEM) (Gibco, Paisley, UK; Ref. no. 11995; supple-
mented with 10% fetal bovine serum and 164 IU/mL of penicillin G,
50 mg/mL of gentamicin, and 0.25 mg/mL of fungizone). Individual
puromycin-resistant, Lifeact–mEGFP-positive cell clones were picked
by standard limiting dilutionwhen cultured in the presence of puromy-
cin (ﬁnal concentration 7 μg/mL; Sigma-Aldrich, St. Louis, MO). A cell
line (RAW264.7-H10) with high potential to differentiate into OCs
was used in the experiments.
2.2. shRNA targeting Rac1 by pSIREN-RetroQ-DsRed-Express
Oligos Rac1shRNA top strand 5′-GATCCAGACAGACGTGTTCTTAATT
TGTTCAAGAGACAAATTAAGAACACGTCTGTCTTTTTTTACGCGTG-3′ and
bottom strand 5′-AATTCACGCGTAAAAAAAGACAGACGTGTTCTTAATT
TGTCTCTTGAACAAATTAAGAACACGTCTGTCTG-3′were annealed and li-
gated into pSIREN-RetroQ-DsRed-Express (Clontech, Mountain View,
CA; Cat. no. 632487). The resulting vector and the packaging plasmid
pVSV-G (Clontech) were co-transfected into GP-293 cells (Clontech)
with FuGENE® HD Transfection Reagent. Retrovirus delivered shRNA
targeting mouse Rac1 (underlined sequence) [34] was prepared for
transfections and was used to knock down Rac1 in RAW264.7-H10
cells. A sense-only insert (top strand 5′-GATCCGTGCGTTGCTAGTACC
AACTTCAAGAGATTTTTTACGCGTG-3′, bottom strand 5′-AATTCACGCG
TAAAAAATCTCTTGAAGTTGGTACTAGCAACGCACG-3′) in the same vec-
tor containing the sense strand of the targeted luciferase (underlined
sequence) was used as the negative control. DsRed-positive cell clones
were established with a standard limiting dilution method.
2.3. Tartrate-resistant acid phosphatase, actin staining and osteoclast
resorption
TRAcP staining was performed as described [35]. Paraformaldehyde
(PFA, 4%)-ﬁxed cells were rinsed twice with phosphate-buffered saline
(PBS) and TRAcP activity was demonstrated by incubating cells in a so-
lution of naphthol AS-BI phosphate (Sigma) and fast red TR salt (Sigma)
in 0.2 M acetate buffer (pH 5.2) containing 100 mM sodium tartrate
(Sigma) at 37 °C for 10 to 15 min. TRAcP stained cells were counter-
stained with 4′, 6-diamidino-2-phenylindole (DAPI) (Sigma, Cat. no.
D9542; 0.165 μM in 0.1% Triton X-100/PBS) for 10min at room temper-
ature (RT) in dark to determine the number of nuclei. Images were
obtained with Nikon Eclipse E1000 microscope.
For staining actin ﬁlaments, cells were ﬁxed, rinsed with PBS,
incubated with 100 mM glycine in Tris-buffered saline (TBS) (pH 7.5,
quenching buffer; 10 min), permeabilized in 0.1% Triton X-100 (in
PBS; 3–5min), rinsedwith PBS and stainedwith tetramethylrhodamine
(TRITC)-conjugated phalloidin (Molecular Probes, Eugene, OR) and
imaged by confocal microscopy. For resorption assays, OCs formed on
dentine sections of narwhal tusks were removed using 6–10% bleach
(NaOCl) for 5 min. The slices were stained with 1% toluidine blue
(w/v) and 1% sodium borate (w/v) for 30 s.
2.4. Apatite-coated coverslips
Apatite-coated coverslips (ACCs) were prepared as described
[25,36]. Brieﬂy, circular glass coverslips (25-mmdiameter, VWR, Toron-
to, ON) were coated with type I collagen (1 mg/mL) and incubated for
6 days at 37 °C in 3 mL of 200 mM TBS containing alkaline phosphatase
(0.13 mg/mL, Sigma), egg yolk phosvitin (0.13 mg/mL, Sigma), and the
cross-linking reagent dimethyl suberimidate hydrochloride (1 mg/mL,
Sigma) in 6-well plates. The cross-linked, collagen-coated glass slides
were washed several times with TBS to remove unreacted chemicals
and by-products, incubated for 3 h at 37 °C in 3mL of 200mMTBS con-
taining alkaline phosphatase (0.13 mg/mL) and egg yolk phosvitin
(0.13 mg/mL), and incubated for 20 h at 37 °C in 3 mL of 6 mM calcium
Fig. 1. Importance of actin ﬁlaments in osteoclast function. (A) RAW264.7 cells (passage 3) were infected with retroviruses released from a packaging cell line GP-293 and co-transfected
with pMSCVpuro–Lifeact–mEGFP and pVSV-G. The RAW264.7-H10 cell line stably expressing Lifeact–mEGFP was established by standard limiting dilution. (B) RAW264.7-H10 cells
were differentiated into TRAcPpositivemultinuclearOC-like cells that formed sealing zones onapatite and resorption pits on dentine. (C) Lifeact–mEGFPenablesmonitoring actinﬁlament
dynamics in OCs. Podosome clusters, rings and belt were seen in RAW264.7-H10 cell-derived OCs cultured on glass. The distribution of F-actin indicated by Lifeact–mEGFP tightly
co-localized with TRITC-conjugated phalloidin-stained actin ﬁlaments.
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and 20-hour incubationswere repeated 7 to 14 times, depending on the
amount of precipitated calcium phosphate. After washing with TBS,
slides were dried and the surface of one side was treated with 0.1 M
HCl solution to remove the precipitate and clear the surface. Day 3
OCs generated on plastic were detached with pre-warmed 2 mM
EDTA/PBS and re-plated onto ACCs overnight to view sealing zone
formation.
2.5. Live cell imaging
Cells were seeded (0.5 × 106 cells) onto circular cover-glasses
(25-mm diameter) (VWR, Radnor, PA) in 6-well plates in complete
DMEM containing 60 ng/mL sRANKL (expressed and puriﬁed
from pGEX-4 T-1-murine sRANKL construct; provided by Morris F.
Manolson) for two days. Cells were sRANKL-starved overnight and
transferred into a steel Attoﬂuor® cell chamber (Molecular Probes;
Cat. no. A-7816) ﬁlled with complete DMEM containing sRANKL
(60 ng/mL). The chamber was loaded onto the heating stage (37 °C)
of a Leica DMIRE2 confocal microscope (Wetzlar, Germany) with a 5%
CO2 atmosphere. Live cell imaging was recorded for 4 to 12-hour
periods at 1 minute intervals.
2.6. Osteoclast generation from primary bone marrow monocytes
All procedures described were performed in accordance with the
Guide for the Humane Use and Care of Laboratory Animals and were
approved by the University of Toronto Animal Care Committee. Bone
marrow was harvested from tibia and femurs of mice and a single-cell
suspension was prepared by gently aspirating the marrow several
times followed by re-suspension in complete (with serum andFig. 2. Osteoclast formation is actin-dependent. (A) RAW264.7-H10 cells were treatedwith cyt
TRAcP positive OCs were formed from control cells treated with DMSO but not in cells treated
(10×) were quantiﬁed. Data are mean ± standard deviation. (C) PreOC migration, a prerequ
live cells (Supplemental Video 1-cytochalasin D; Video 2-DMSO). The time after the ﬁrst frameantibiotics) minimum essential medium alpha (α-MEM) (Life Technol-
ogies, Grand Island, NY; Cat. no. 12561; 1 × 106 cells/mL) and incubated
in T-75 cm2 ﬂasks overnight. The following day, cells were centrifuged
over Ficoll-Paque™ PLUS, at 300 ×g for 30 min at RT, washed twice
with basic α-MEM and counted before the last wash. Cells (1 × 105
cells/well) were plated into a 24-well plate on the plastic or glass in
complete α-MEM containing 20 ng/mL M-CSF and 60 ng/mL sRANKL.
The medium was changed every other day and cells were rinsed with
pre-warmed PBS at day 6 and ﬁxed with PFA (4%). The formation of
OCs was conﬁrmed with TRAcP staining.
2.7. Immunoﬂuorescence
Mononuclear preOCs or immature multinuclear OCs derived from
the original RAW264.7 cells were used for myosin-X or DC-STAMP
staining. RAW264.7 cells (passage 6 to 10) were plated in 12-well
Falcon® plates (5 × 104 cells/well) in 1 mL complete DMEM containing
sRANKL (60 ng/mL) for two days and then starved of sRANKL for 6 h.
The cells were re-stimulated with sRANKL for the last 2 h of culture.
The cells were washed with pre-warmed PBS and ﬁxed in PFA (4%).
The ﬁxed cells were incubated in quenching buffer for 10 min, triton
X-100 (0.1% in PBS) permeabilized and blocked with bovine serum
albumin (BSA) (1% in PBS containing 0.1% triton X-100) at RT for
30 min. The cells were incubated with primary antibodies, either rabbit
anti-human/mouse myosin-X (Novus Biologicals, Cambridge, UK; Cat.
no. 22430002; 1:200), or monoclonal anti-human/mouse DC-STAMP
(MilliporeTM, Temecula, CA; Cat. no. MABF39 (clone 1A2); 1:100) at
4 °C overnight. The cells were stained with primary antibody-host-
speciﬁc secondary antibodies, i.e. Alexa Fluor® 488-conjugated goat
anti-rabbit IgG (H + L) (Molecular Probes, Cat. no. A-11008; 1:300) or
Alexa Fluor® 647-conjugated goat anti-mouse IgG (H + L) (Molecularochalasin D orwith DMSO during a 4-day sRANKL-induced OC differentiation period. Large
with cytochalasin D. (B) TRAcP positive multinuclear cells formed per microscopic ﬁled
isite for cells to fuse, was inhibited by cytochalasin D, as shown in time-lapse imaging of
is indicated in hours. Size of cell aggregates is shown in panel (D).
1719Y. Wang et al. / Biochimica et Biophysica Acta 1853 (2015) 1715–1724Probes, Cat. no. A-20990; 1:150) at 37 °C for an hour. The cells were
double stained with Alexa Fluor® 488 phalloidin (Life Technologies,
Eugene, OR; Cat. no. A12379; 1:40. Stock concentration 6.6 μM) at RT
for 20 min. Nuclei were counterstained with DAPI. Images were taken
using a Nikon microscope (Eclipse E1000).
2.8. Three-dimensional cell cultures
A three-dimensional (3-D) cell culture model [37] was used to
study RANKL-induced fusopod formation. Polyvinyl pyrrolidone free
(PVP-F) polycarbonate membrane ﬁlters (Neuro Probe, Gaithersburg,
MD; part no. 30PFRS, 3 μm pore size; 130 × 130 mm) were treated
at 60 °C for an hour in 0.5 M acetic acid solution. The membraneFig. 3. Osteoclast formation is mediated by fusopods. (A) RAW264.7-H10 cells were stimulated
added back 12 h later. Cells weremonitored by confocal microscopy. A representative sample a
cell are markedwith a red and a yellow star, respectively. The fusion process is separated into p
arrow indicates the direction of cell movement. The red arrows indicate ﬁlopodia formation i
through a fusopod bridge (yellow arrow) that forms between cells. Note that a fusing cell m
Fig. 5B, wild-type control). The time after the ﬁrst frame is indicated in minutes. Photomicr
RAW264.7 cells cultured on glass were immunostained for myosin-X (red), stained for actin
the original RAW264.7 cells were cultured on glass and immunostained for DC-STAMP (red) an
to fuse. The patterns are speciﬁed as mononuclear–multinuclear (mono–multi), multi–multi aﬁlters were rinsed thoroughly and coated in a ﬁbronectin solution
(100 ng/mL) overnight at 37 °C. Soluble RANKL-primed (two days)
original RAW264.7 cells (6 × 106, passage 6 to 10) were starved of
sRANKL for 6 h and re-suspended in 50 mL complete DMEM. The
cell suspension was plated on the top side of the membrane. Cells
on the membrane were incubated in a custom-designed cell culture
chambers for two additional hours to allow fusopod formation on
the bottom side of the membrane, where 50 mL complete DMEM
containing 120 ng/mL sRANKL had been loaded earlier. Membranes
were ﬁxed in PFA (4%). Parts of the membrane were immunostained as
described above to visualize proteins of interest by confocal microscopy.
In some experiments, 24-well Costar® transwell permeable supports
(3.0 μm pore size, 6.5 mm diameter, 2 × 104 cells/well) were used.with sRANKL for two days. The cells were sRANKL-starved overnight. Soluble RANKL was
nd schematic diagram of cells are highlighted (time inminutes). The founder and follower
hases of cell migration, searching (ﬁlopodia) and fusion (fusopod) steps. The dashed white
n the front of the founder cell, and in the tail of the follower cell. Cell fusion is mediated
ay extend several fusopods to connect with different fusion partners (see Fig. 3D and
ographs were cropped from Video 3. (B) pOCs/immature OCs derived from the original
ﬁlaments (green) and counterstained with DAPI. (C) pOCs/immature OCs derived from
d counterstained with DAPI. (D, E) Cell fusion patterns in sRANKL-treated BMMs induced
nd mono–mono nuclear cell fusion.
Fig. 4. Soluble RANKL-induced fusopod formation of cells cultured in a three dimensional
system. (A) A schematic based on reference [61] depicts the 3-D cell culture system. Cells
were stained for actin ﬁlaments (B–D, green), immunostained for myosin-X (C, red), or
DC-STAMP (D, red) and counterstained with DAPI. The top surface of the ﬁlter used in
the 3-D system is marked with a dashed-line.
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All experiments were conducted in triplicate. Means and standard
error of means were computed. Co-localization of confocal microscopy
images depicting two different ﬂuorescent dyes was quantiﬁed using
Pearson's correlation coefﬁcient, rp, which employed the Pearson–
Spearman correlation co-localization plug-in [38,39] for ImageJ. Data
were plotted using customized algorithms in R language (TheR Founda-
tion for Statistical Computing, Vienna, Austria). Student's t-testwasused
for comparing two groups. Statistical signiﬁcance was computed and
indicated for levels of p b 0.05 (*), p b 0.01 (**) and p b 0.001 (***).
3. Results
3.1. mEGFP–Lifeact enables monitoring of actin assembly in preOCs
As actin polymerization drives the extension of lamellipodia and
ﬁlopodia [40], we monitored actin assembly during preOC fusion by
stably infecting RAW264.7 cells (passage 3) with a retrovirus encoding
mEGFP-tagged Lifeact at the C-terminal. This approach enabled real-time
imaging of actin ﬁlament formationwithout interference of other cellular
processes [41] (Fig. 1A). Transfected cells exhibited osteoclastogenesis in
an identical manner to non-transfected parental RAW264.7 cells. After
sRANKL stimulation the cells fused to become multinucleated cells
(Fig. 1B). The distribution of Lifeact–mEGFP in the fused cells was spatial-
ly consistent with TRITC-conjugated phalloidin-stained actin ﬁlaments
(Fig. 1C). The tight spatial co-localization of Lifeact with phalloidin was
conﬁrmed by Pearson correlation analysis (rp N 0.903; two-tailed p =
0.0003). In long-term imaging experiments we found that Lifeact did
not exhibit detectable photobleaching after up to 12 h in fusion assays.
OCs derived from RAW264.7-H10 cells formed podosome clusters, rings
and belt conﬁgurations on glass slides. Further, Lifeact-expressing cells
formed sealing zones on apatite-coated coverslips and created resorption
pits on dentin slices (Fig. 1B). Collectively these data indicate that trans-
fection of preOCs with ﬂuorescent-tagged Lifeact does not interfere
with OC function and was therefore an appropriate tool for studying
actin dynamics in fusing preOCs.
3.2. Actin assembly affects osteoclast fusion
Direct evidence for the involvement of actin assembly in osteoclasto-
genesis has not been demonstrated, althoughwe recently proposed that
the actin-binding protein adseverin may regulate this process [42].
To examine the nature of actin ﬁlament structures associated with
osteoclastogenesis, we treated cells with cytochalasin D to depolymer-
ize ﬁlaments in sRANKL-induced RAW264.7 cells undergoing OC differ-
entiation. In cells ﬁxed at day 4 and stained for TRAcP to identify OCs,
both cytochalasin D-treated and control cells expressed TRAcP. Cells
treated with cytochalasin D exhibited greatly reduced cell fusion
(Fig. 2A). As the formation of multi-nucleated cells (≥10 nuclei/cell)
was almost completely inhibited (p b 0.001) by cytochalasin D at
the pre-fusion stage of osteoclastogenesis, actin polymerization
evidently plays an important role in later stages of OC differentiation
but not in earlier stages (i.e. the OC-commitment stage; Fig. 2A, B).
Treatment of cells with cytochalasin D also diminished cell migration
(Fig. 2C and D; compare Supplemental Video 1-cytochalasin D and
Video 2-DMSO).
3.3. Multinucleation in OCs is dependent on fusopod formation
Cell fusion is a dynamic process and it has been proposed that during
macrophage fusion, one cell takes the lead in the internalization of an
adjacent cell [43], an assertion that has been corroborated by others
[5,44]. In time-lapse recordings of RAW264.7-H10 cells we observed
similar phenomena involving pairs of cells in which a designated
“follower cell” tethers to a “founder cell”. We designated the followercell as the (usually) smaller cell that was identiﬁed in adjacent cell
pairs. The follower cell is internalized by the cell behind it, which we
designate as the (usually) larger founder cell and which has been
described previously [5,13].
We divided the process of OC fusion into four steps (Fig. 3A; supple-
mental Video 3). First, the founder cell moves toward a follower cell;
both cells adopt a teardrop shape during the migration step. At the
head of the founder cell and the tail of the follower cell multiple
ﬁlopodia are formed. Next, the head of the founder cell and the tail of
the follower cell begin to fuse through long, ﬁnger-like extensions
which we designate as fusopods. A fusopod bridge is established be-
tween fusing cells and the follower cell is internalized by the founder
cell (Fig. 3A). We deﬁne fusopods as cell extensions that are stained
for myosin-X (see below) and are enriched with ﬁlopodia [45] at their
leading edges. Fusopods are much broader than individual ﬁlopodia
and are formed from ﬁlopodia precursor structures (Fig. 3A).We exam-
ined by immunostaining whether sRANKL-induced fusopods exhibited
the classical tip marker, myosin-X [46]. Imaging showed that myosin-
X localized to the tips of sRANKL-induced cell extensions (Fig. 3B). Of
a total of 68 cells that were involved in 33 fusion events (two cells
fused in each of the 32 events, and four cells fused simultaneously in
one event), 61 cells exhibited fusopod formation during fusion, indicat-
ing that the formation of fusopods is a high probability event in cell fu-
sion among preOCs, immature OCs, and between preOCs and immature
OCs. Quantitative analysis of preOCs showed that cells extended 7.0 ±
0.4 fusopods/cell. Fusopods were 2.5 ± 0.2 μm in length. The fusion of
RAW264.7 cells mediated by cell extensions was similar to the fusion
1721Y. Wang et al. / Biochimica et Biophysica Acta 1853 (2015) 1715–1724processes observed in primary bonemarrowmonocyte (BMM)-derived
OCs (Fig. 3D, E).
Cell migration is a fundamental process in preOC fusion [47,48] and
migration is correlated with actin ring expansion [26]. To obtain an im-
proved understanding of how actin ring formation is involved in preOC
migration and cell fusion, we treated RAW264.7-H10 cells (day 2 or
3) with sRANKL. Imaging showed that sRANKL promotes cell motility
and that actin rings consistently appeared at the leading edge of motile
cells (Supplemental Video 4).3.4. Characterization of fusopods in 3-D cultures
As the formation of cell extensions is important for cell fusion [10,17,
27,28], we examined sRANKL-induced fusopod formation in a 3-D cul-
ture system [37] that featured a sRANKL gradient (Fig. 4A). With this
system, sRANKL-induced cell–cell fusion was evidently dependent on
fusopods (Fig. 4B). Myosin-X staining at the tips of cell extensions
showed that sRANKL triggered the formation of authentic fusopods
(Fig. 4C). We also studied the distribution of DC-STAMP in 3-D cultures
of cells at the fusion stage (Fig. 4D). Consistent with the distribution of
DC-STAMP staining in cells cultured on glass (Fig. 3C), there was uni-
form staining of DC-STAMP around the periphery of cells in 3-D cultures
but DC-STAMP was not speciﬁcally localized to the tips. This pattern of
staining indicates that DC-STAMP may not provide the spatial seques-
tration of attachment systems or protrusion mechanisms that enable
initial fusion events that are restricted to the tips of fusopods.Fig. 5. Rac1 plays a role in osteoclast formation and actin organization in late-stage osteoclasts. L
retroviral-based delivery system (pMSCVpuro) to generate RAW264.7-H10 cells. RAW264.7-H1
tor expressing Rac1 shRNA. (A) A Rac1 knockdown cell line was cloned by standard limiting d
RANKL-induced OC formation. Cell fusion ability was reduced by ~5-fold in Rac1 knockdown ce
of Rac1. Mature OCs formed interrupted podosome belts on glass in Rac1 knockdown cells (Vi3.5. Small GTPases Rac1 and osteoclastogenesis
As Rac1 is an important regulator of actin cytoskeletal remodeling
[49], we examined the role of Rac1 in osteoclastogenesis using stable
knockdown of Rac1 in RAW264.7-H10 cells (Fig. 5A). Rac1 knockdown
markedly reduced osteoclastogenesis (Fig. 5B, C; p b 0.001) and
disruption of the ring of actin ﬁlaments around the entire cell periphery
in mature OCs (Fig. 5D; supplemental Video 5-Rac1-null and Video
6-wild-type). These ﬁndings are consistent with previous studies dem-
onstrating that Rac1 is needed for osteoclastogenesis and bone resorp-
tion [50,51]. Further, wild-type cells treated with sRANKL formed
many more fusopods than sRANKL-stimulated Rac1 knockdown cells
(p b 0.001; Fig. 6).
3.6. Actin waves are involved in cell fusion
Time-lapse microscopy of RAW264.7-H10 cells showed waves of
actin assembly in fusing cells (Fig. 7). Actin ﬁlament waves, which
were particularly prominent in larger fusing OCs with N5 nuclei, coa-
lesced and contributed to the increased width of fusopods at contact
sites. These waves traveled around the cell periphery in the subcortical
zone and fusion was only completed after these waves entered
fusopodial bridges that connect the two initially fusing cells. We noted
that where fusopodial bridges widened, the follower cell (a fusion-
competent mononuclear cell or small multinucleated cell) moved
toward the founder cell (multinucleated, larger than the follower cell),
thereby enabling subsequent cell fusion (Supplemental Video 7).ifeact–mEGFPwas stably introduced into low passage RAW264.7 cells as described using a
0 cells were infectedwith retroviruses prepared frompSIREN-RetroQ-DsRed-Express vec-
ilution. The cell line expresses DsRed when Rac1 is deleted. (B and C) Rac1 plays a role in
lls. (D) The formation of rings of actin ﬁlaments in late-stage OCs was affected by deletion
deo 5), whereas podosome belts in wild-type cells were continuous (Video 6).
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PreOCs migrate towards one another, recognize fusion-competent
cells, and then fuse to formmultinucleated OCs [9,52]. While the differ-
entiation of OCs is known to be initiated by RANKL, the fusion program
that mediates multi-nucleation is not well-deﬁned [11]. To study the
formation of multi-nucleated OCs we developed an assay that enabled
tracking of OC fusion and actin polymerization in real-time. This assay
enables detailed study of RAW264.7 cell-derived preOCs at a fusion-
competent state. RAW264.7 cells are treated for two days with sRANKL
and sRANKL is removed for 12 h to enhance the sensitivity of cells to
freshly added sRANKL. Fusion events are initiated by the re-addition of
sRANKL, which reactivates cells and promotes fusion events. Under
these experimental conditions, cells are rapidly activated and undergo
numerous sequential fusion events that can be captured and analyzed
by time-lapse microscopy. While the current experiments were
designedmainly to capture cell fusion events between immaturemulti-
nucleated OCs, the assay can be modiﬁed so that cells with one or two
nuclei can be tracked at earlier stages of differentiation.Fig. 6. Fusopod formation in fusing osteoclasts is Rac1-dependent. Wild-type control and Rac
RANKL overnight. Cells were detached with a cell scraper and loaded into Boyden chamber in
to attach. Soluble RANKL (100 ng/mL) was used to promote fusopod formation over 2 h. (A) T
in (A) is quantiﬁed as in (C). (B) A cropped and enlarged image of wild-type cells stimulatedwitFor this study we developed a cell line (RAW264.7-H10) that stably
expresses the actin probe Lifeact–mEGFP [41], which ﬂuoresces when
bound to actin ﬁlaments and enables observation of actin ﬁlament
dynamics in live cells during osteoclastogenesis. The Lifeact–mEGFP
system, when combined with time-lapse imaging, permitted visualiza-
tion of actin ﬁlament dynamics, cell–cell attachment events and subse-
quent fusion processes in real-time. The development of this assay for
imaging of OC fusion enabled detailed analysis of actin-mediated
fusopod formation and stabilization, which leads to OC differentiation.
Both cell migration and fusion were inhibited by treatment of cells
with the actin depolymerizing agent cytochalasin D. Rac1, which regu-
lates osteoclastogenesis and OC function [50,51,53], was also important
in OC fusion events: when Rac1was knocked down in cells, cell sizewas
decreased and the formation of normal actin structures was disrupted.
In both of these sets of experiments, actin ﬁlament assembly was
disrupted and cells were unable to form fusopods. Collectively these
data indicate that actin assembly is important in fusion events,
which explains the reduced cell fusion and cell size when actin assem-
bly was inhibited.1 knockdown cells were stimulated with sRANKL for two days. The cells were starved of
serts (3 μm pore size, 20,000 cells/well). Cells were incubated for an hour to allow them
hree-dimensional confocal images of cells cultured on ﬁlters. Fusopod formation shown
h sRANKL. Fusopod formation is shown in the holes of theﬁlter (dashed lines underneath).
Fig. 7.Actinwaves accompany cell fusion. RAW264.7-H10 cellswere stimulatedwith sRANKL for two days. The cellswere starved of RANKL overnight. On the next day, sRANKLwas added
to cultures and cell fusion was imaged by confocal microscopy in real-time. Note that actin waves (speed= 6 μm/min) were seen in both the founder (red star) and the follower (yellow
star) cells. Eventually, an actin wave from the founder cell crossed the connecting bridge and the cells fused. Time after the ﬁrst frame is indicated in minutes. (Video 7).
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tiation, when many long, thin extensions were observed in each cell.
These extensionswere enrichedwith ﬁlopodia, as reported for undiffer-
entiated RAW264.7 cells [10]. At later time points during the differenti-
ation process the cell extensions that we designate as fusopods,
elongated to facilitate bridging and fusion processes between two or
more cell types.While themajority of fusion eventswere initiated at ad-
jacent fusopods, some cells appeared to fuse at the contacts of broad
surfaces only. Fusion events inwhichno fusopodswere involved, gener-
ally occurred at later time intervals of fusion assays. In agreement with
our ﬁndings, another group has observed a lack of ﬁlopodia and
lamellipodia formation at days 5 and 6 in OCs derived from RAW264.7
cells [10], when fusion is much less likely to occur.
Similar to previous observations [54,55], we found that cell fusion is
not a random event that occurs between two adjacent cells. Instead,
founder cells initiate fusion based in part on cell migration and on the
recognition of other fusion-competent cells. In addition to serving as
one of themain drivers of cell motility, we found that the actin cytoskel-
eton plays a central role in OC fusion. Immediately prior to fusion,
fusopods are extended between two adjacent cells and, upon contact,
become a fusopodial bridge. In general, fusopods formed at the leading
edge or tail of a migrating founder or follower cell, respectively. The
bridge generated by the formation of the fusopods may provide a con-
duit through which the ﬁrst observable movement of cytoplasmic con-
tents occurs between two previously separate cells. Indeed, waves of
actin ﬁlaments moved from one cell to another through the bridges,
which link cells through a shared plasma membrane. These observa-
tions are in agreementwith previously proposed hypotheses describing
the reorganization of the plasma membrane during cell fusion. It is
thought that cells fuse via tethering of aqueous pores; the expansion
of the pores leads to union of the cytoplasm of the two cells [56]. In
this context, the plasmamembrane of a cell can be subdivided into sev-
eral distinct micro-domains with variable protein and cholesterol com-
positions [57]. These micro-domains are motile and function as
platforms for the attachment of proteins andmembranes during cellmi-
gration. Conceivably, the fusopod forms in a fusogen-rich region in asso-
ciation with a membrane micro-domain [58].
The fusogens involved in OC fusion are not deﬁned but may be
related to a ligand-receptor interaction mechanism [59]. A number
of molecules including interferon-gamma, intercellular adhesion
molecule-1, lymphocyte function-associated antigen 1 and DC-STAMPhave been implicated in macrophage cell–cell fusion [43]. The involve-
ment of syncytin-1 in human osteoclast fusion has been reported [60].
Other syncytin family proteins (syncytin-2 and the fusogenic retroviral
envelope protein P(b)) have been suggested as likely candidates for au-
thentic cell–cell fusogens in primate cells [58]. In terms of the proposed
fusionmechanism in OCs, we envisage that when two preOCs are in ap-
position, a fusopod is extended. If both cells express the same
homotypic intercellular adhesion molecule (e.g., DC-STAMP), then pro-
ductive intercellular adhesion can occur at the site of fusion. In this
model, intercellular adhesion molecules are essential for preOC fusion
but they do not deﬁne the site of initial fusion. Althoughwe did not out-
line how actin assembly is spatially regulated at the fusion site, we have
shown that fusopods are important for successful multi-nucleation.
Hopefully, more in-depth application of the 3-D cell culture system
used here may facilitate identiﬁcation of the fusogens that regulate OC
fusion [61].
In summary, we describe a role for actin-dependent cell extension
formation in preOC fusion, suggesting that actin ﬁlament assembly is a
target for control of bone resorption. Future experiments might address
potential molecules and processes that regulate fusopod formation and
the fusion phase of osteoclastogenesis. This approach could enable iden-
tiﬁcation of novel pharmacological targets that regulate pathological
bone resorption while minimizing the side-effects associated with
current drugs.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2015.04.001.
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